.Pharmacolibrary.Drugs.ATC.J.J01XD01_1 .Pharmacolibrary.Drugs.ATC.J.J01XD01_1| name: | Metronidazole_1 | |
| ATC code: | J01XD01_1 | route: | intravenous |
| compartments: | 2 | |
| dosage: | 500 | mg |
| volume of distribution: | 39.0 | L |
| clearance: | 65 | mL/min |
| other parameters in model implementation | ||
Metronidazole is a nitroimidazole antimicrobial agent used primarily to treat infections caused by anaerobic bacteria and certain parasites. It is approved for use in bacterial vaginosis, trichomoniasis, giardiasis, amebiasis, and various anaerobic infections. Metronidazole is widely used in clinical practice, both in hospital and outpatient settings.
Pharmacokinetic parameters following single intravenous infusion in healthy adults.
Suyagh, M, et al., & McElnay, JC (2011). Metronidazole population pharmacokinetics in preterm neonates using dried blood-spot sampling. Pediatrics 127(2) e367–e374. DOI:10.1542/peds.2010-0807 PUBMED:https://pubmed.ncbi.nlm.nih.gov/21220396
Sullins, AK, & Abdel-Rahman, SM (2013). Pharmacokinetics of antibacterial agents in the CSF of children and adolescents. Paediatric drugs 15(2) 93–117. DOI:10.1007/s40272-013-0017-5 PUBMED:https://pubmed.ncbi.nlm.nih.gov/23529866
Arnold, DT, et al., & MacGowan, A (2024). Antibiotic pharmacokinetics in infected pleural effusions. Thorax 79(9) 883–885. DOI:10.1136/thorax-2023-220402 PUBMED:https://pubmed.ncbi.nlm.nih.gov/38964858